Reading File

Running Command

cd /tmp/workspace/attachments/bab77260-6656-4281-97eb-9e0677fe792c/ && python3 -c " import pdfplumber with pdfplumber.open('Term 3_Module 5_ practicl1_2024 UCFM.pdf') as pdf: print(f'Total pages: {len(pdf.pages)}') for i, page in enumerate(pdf.pages): print(f'\n--- PAGE {i+1} ---') text = page.extract_text() if text: print(text) else: print('[No extractable text]') "

Reading File

Finding Sources

I now have sufficient information from both the PDF and the medical library to provide comprehensive answers to all questions in the practical. Let me compile the full answer.

Here is a complete guide to all the questions in Practical 1, Term 3 Module 5 covering both case scenarios.

PRACTICAL 1 - COMPLETE ANSWER GUIDE

CASE SCENARIO 1 - ALT in Liver Disease (Mr. Nimal Perera)

Q1. Specimen collection tube for ALT; type of fluid after centrifugation

Use a plain (red-top) tube or a serum separator tube (SST/gold-top) - both are additive-free, allowing blood to clot. After centrifugation, you obtain serum (the clear, straw-yellow supernatant fluid, free of cells and clotting factors).

Do NOT use an EDTA (purple-top) or heparin (green-top) tube, as these anticoagulants interfere with enzymatic assays.

Q2. ALT Assay - Principle (as provided in the kit)

The coupled enzyme assay measures ALT activity:

ALT reaction: 2-oxoglutarate + L-alanine → L-glutamate + pyruvate
LDH reaction: pyruvate + NADH + H⁺ → L-lactate + NAD⁺

NADH absorbs at 340 nm. As NADH is consumed in the second reaction, absorbance decreases. The rate of decrease is directly proportional to ALT activity.

Q3. Measuring the decrease in absorbance of NADH

Record absorbance at 340 nm at fixed time intervals (e.g., every 1 minute for 3 minutes). Calculate the ΔAbsorbance/minute (the rate of absorbance decrease). This rate is used to calculate ALT activity in U/L.

Q4. Is this a kinetic assay or endpoint assay?

This is a kinetic (rate) assay.

Explanation: A kinetic assay measures the rate of change of absorbance over time (ΔA/min), which is proportional to enzyme activity. An endpoint assay measures absorbance at a single fixed point after the reaction has gone to completion. Since ALT activity is calculated from the continuous rate of NADH consumption (not a fixed endpoint), it is kinetic. This is the preferred method for enzyme assays because it is more accurate and less affected by interfering substances.

Q5. What is a reagent blank?

A reagent blank is a cuvette/tube that contains all the assay reagents (substrates, buffer, coenzymes) but NO patient sample - instead, distilled water (or a protein-free solution) replaces the sample volume.

Q6. Why do you need a reagent blank?

The reagent blank accounts for:

Any intrinsic absorbance of the reagents themselves (e.g., NADH in the reagent mixture itself absorbs at 340 nm even before the sample is added).
Any non-enzymatic, spontaneous degradation of NADH in the reagent.
Any optical imperfections in the cuvette or light scatter in the reagent.

By zeroing the spectrophotometer against the reagent blank, you ensure that only the absorbance change caused by the patient's enzyme activity is measured - eliminating background interference and improving accuracy.

Q7. Calculating Mr. Perera's ALT activity

The formula used is:

ALT (U/L) = (ΔA/min × Total volume × 1000) / (ε × Light path × Sample volume)

Where:

ΔA/min = rate of decrease in absorbance at 340 nm
ε (molar absorptivity of NADH) = 6.22 L/mmol/cm (or 6220 L/mol/cm)
Light path = 1 cm (standard cuvette)
Volume correction: Total reaction volume / sample volume

Most kit inserts provide a simplified formula or a factor (F):

ALT (U/L) = ΔA/min × F

Record the ΔA/min from your three readings, apply the kit's factor, and report in U/L.

(The exact numerical result will depend on the absorbance readings you measured in the practical. The reference range for ALT in serum is approximately 7-56 U/L in adults.)

Q8. Commenting on the result

If ALT is elevated above the reference range (>56 U/L): This is consistent with hepatocellular damage/fatty liver disease (non-alcoholic fatty liver disease, NAFLD), which is expected given Mr. Perera's elevated triglycerides, LDL, and history suggesting metabolic syndrome. ALT elevation in fatty liver is typically mild-to-moderate (1-3× upper limit of normal). The GP was correct to screen for fatty liver.
If ALT is within reference range: The test does not exclude early fatty liver, as ALT can be normal in mild steatosis.
Note: ALT is more liver-specific than AST, making it the preferred marker for liver cell damage. As noted in Schwartz's Principles of Surgery, AST is found in heart, muscle, kidney and brain as well, while ALT is more specific for liver injury.

Q9. Explaining the ALT result to Mr. Nimal Perera (lay explanation)

"Mr. Perera, this test measured an enzyme called ALT in your blood. ALT is normally found inside liver cells. When liver cells become damaged or inflamed - for example, from fat building up inside them - they release ALT into the bloodstream. A high level of ALT in the blood therefore tells us that some liver cells may be stressed or injured.

In your case, given that your blood fats (cholesterol and triglycerides) are elevated, fat can deposit in the liver - a condition called fatty liver. This is very common with the kind of lipid changes you have.

The good news is that fatty liver is often reversible with lifestyle changes - a healthy diet, regular physical activity, and managing your blood sugar and lipid levels. This test result helps us monitor your liver and decide if further investigations or treatment are needed."

Reflective Writing (Case 1)

One interesting thing learned: The coupling of two enzyme reactions to indirectly measure ALT activity using NADH as an optical reporter - a concept used widely in clinical biochemistry.
Plan to learn more: Read the relevant section in Harper's Illustrated Biochemistry (Chapter on amino acid metabolism and transaminases); search for case studies on NAFLD biochemistry; review how kinetic enzyme assays differ from endpoint assays in more detail.

CASE SCENARIO 2 - Bilirubin Measurement

Q1. Specimen collection tube for bilirubin; type of fluid after centrifugation

Use a plain (red-top) tube or SST (gold-top) - same as for ALT - to obtain serum.

Important precautions: Bilirubin is highly photosensitive (degraded by light), so:

Protect the sample from light immediately after collection (wrap the tube in aluminum foil or use amber-colored tubes).
Transport and store in the dark, at 4°C if assay is delayed.
Avoid excessive agitation or prolonged exposure at room temperature.

Q2. Colour of an icteric sample

An icteric (jaundiced) serum sample appears deep yellow to orange-yellow (instead of the normal pale straw-yellow colour). This is due to the high concentration of bilirubin pigments in the serum. Severely icteric samples may appear brownish-orange.

Q3. Precautions for bilirubin sample storage/transport

Protect from light - bilirubin photo-oxidizes rapidly; wrap in foil or use opaque containers.
Keep cool - store at 2-8°C; analyze within 2-4 hours of collection if possible.
Avoid haemolysis - haemolyzed samples interfere with the colorimetric diazo assay and give falsely low bilirubin results.
Avoid lipemia - grossly lipemic samples can cause turbidity and interfere with absorbance readings.
Use appropriate tube - serum (plain) tube preferred; EDTA plasma is acceptable for some methods.

Q5. Comparing absorbance values in the Van den Bergh test

The "Total" bilirubin tube (with alcohol/ammonium sulphate accelerator) will show a higher absorbance than the Direct bilirubin tube (water only).
This is because total bilirubin includes both conjugated AND unconjugated bilirubin. The alcohol solubilizes unconjugated bilirubin so it can also react with the diazo reagent.
The direct (conjugated) bilirubin reacts without accelerator and gives the lower reading.
After adding strong alkali, the azobilirubin product turns from purple to blue and is measured at 600 nm.

Q6. "Direct" vs "Indirect" bilirubin; how to obtain indirect bilirubin concentration

Direct bilirubin (conjugated bilirubin):

Bilirubin that has been conjugated with glucuronic acid in the liver (by UDP-glucuronyl transferase).
It is water-soluble, can be excreted into bile.
It reacts directly with the diazo reagent in an aqueous medium - hence the name "direct."
Elevated in post-hepatic (obstructive) jaundice (e.g., bile duct obstruction, cholestasis) and in hepatocellular disease.

Indirect bilirubin (unconjugated bilirubin):

Bilirubin that is not yet conjugated by the liver; it is bound to albumin in the blood.
It is NOT water-soluble and cannot react directly with the diazo reagent - an organic solvent accelerator (alcohol/caffeine) is required.
Elevated in pre-hepatic (haemolytic) jaundice and in neonatal jaundice.

Calculating indirect bilirubin:

Indirect bilirubin = Total bilirubin - Direct bilirubin

(Normal values: Total bilirubin < 1.0 mg/dL; Direct < 0.3 mg/dL; Indirect < 0.8 mg/dL)

Reflective Writing (Case 2)

Something I did not understand well enough: Why unconjugated bilirubin is not water-soluble, and the exact molecular reason it requires an accelerator to react with diazo reagents.
Plan: Read the bilirubin metabolism chapter in Harper's Illustrated Biochemistry; draw out the full metabolic pathway from haem breakdown to urobilinogen excretion.

SERUM PROTEIN ELECTROPHORESIS

Q1. Principle of serum protein electrophoresis

Serum proteins carry net negative charges at the standard buffer pH used (typically pH 8.6 with barbital or borate buffer). When an electric field is applied, these charged proteins migrate through a porous supporting medium (agarose gel) toward the anode (positive electrode) at rates determined by:

Net charge of the molecule - more negative = faster migration toward anode
Size and shape - smaller/more compact molecules migrate faster
Strength of the electric field - higher voltage = faster migration
Properties of the supporting medium (pH of buffer) - pH determines the ionization state of proteins; at pH 8.6, virtually all serum proteins carry net negative charge
Temperature - affects viscosity of the medium

Proteins with different charge-to-mass ratios migrate at different rates, producing distinct bands (zones) in the gel. These zones are stained with a protein-specific stain (e.g., Coomassie blue or Ponceau S), and the gel is scanned with a densitometer to produce a densitogram/electropherogram with peaks corresponding to each protein fraction.

The five fractions (in order from anode to cathode) are: Albumin, α₁-globulin, α₂-globulin, β-globulin, γ-globulin.

Q2. Electrophoretogram patterns in disease conditions

Disease Condition	Electrophoresis Pattern	Explanation for Change from Normal
Inflammatory process (acute inflammation)	↑ α₁ and α₂ peaks; albumin may be slightly ↓	Acute-phase proteins (α₁-antitrypsin, haptoglobin, α₂-macroglobulin, caeruloplasmin) are synthesised rapidly by the liver in response to inflammation (acute phase response). These elevate the α₁ and α₂ fractions. Albumin (negative acute-phase reactant) may fall mildly.
Chronic inflammation	↑ γ-globulin (broad, diffuse/"polyclonal" hump); ↑ α₂; albumin ↓	Sustained antigenic stimulation leads to polyclonal immunoglobulin production (multiple B-cell clones producing many different antibodies). This produces a broad, diffuse elevation of the γ-fraction - called polyclonal gammopathy. Albumin falls as a negative acute-phase reactant.
Chronic liver cell disease (cirrhosis)	↓ Albumin; ↑ γ-globulin; characteristic β-γ bridging	The damaged liver cannot synthesise albumin adequately → hypoalbuminaemia. The spleen and gut-associated lymphoid tissue produce excess polyclonal immunoglobulins (especially IgA which migrates in the β region). The overlap of IgA into the β fraction creates the classic "β-γ bridge" seen in cirrhosis.
Paraproteinaemia / Monoclonal gammopathy (e.g., Multiple Myeloma)	Tall, narrow, sharp M-spike (monoclonal peak) in the γ (or sometimes β) region	A single malignant plasma cell clone (or a benign clone in MGUS) produces a single homogeneous immunoglobulin (paraprotein/M-protein). Because it is one identical protein, it migrates to exactly the same position, producing a very sharp, narrow, "church steeple" peak - the M-spike. This is the hallmark of monoclonal gammopathy.
Hypogammaglobulinaemia	↓ or absent γ-globulin band; other fractions relatively normal	Deficiency or absence of immunoglobulins (primary: e.g., X-linked agammaglobulinaemia; secondary: e.g., B-cell lymphoma, drug-induced, protein-losing nephropathy). The γ fraction appears flat or markedly reduced.

Key concept for the electrophoretogram table:

Monoclonal (M-spike) = single clone → sharp, narrow peak = malignant/paraprotein
Polyclonal = many clones → broad, diffuse elevation = inflammatory/infectious
Hypoalbuminaemia = reduced synthesis (liver disease, malnutrition) or increased loss (nephrotic syndrome)

Reflective Writing (Electrophoresis)

Something I did not understand well enough: The molecular basis of why IgA specifically causes β-γ bridging in cirrhosis, and how immunofixation electrophoresis (IFE) differs from SPEP in identifying the specific paraprotein class.
Plan to learn more: Watch the video referenced in the practical ("Investigating paraproteins: Electrophoresis, Immunofixation"); read the relevant chapter in Clinical Pathology on plasma cell disorders and SPEP interpretation.
Evidence of learning: Sketch a normal SPEP pattern alongside patterns for MM, cirrhosis, and acute inflammation, labelling each fraction - this reinforces visual recognition of patterns.

Key references used:

Sleisenger and Fordtran's Gastrointestinal and Liver Disease (ALT, bilirubin measurement)
Harrison's Principles of Internal Medicine 22E (bilirubin fractionation)
Harper's Illustrated Biochemistry 32nd Ed (bilirubin metabolism)
Goldman-Cecil Medicine (monoclonal gammopathy, SPEP)
Quick Compendium of Clinical Pathology 5th Ed (bilirubin reference values)
Schwartz's Principles of Surgery 11th Ed (liver function tests, ALT specificity)

This is a shared conversation. Sign in to Orris to start your own chat.